Drug intelligence / Profile preview

HUOXUESHUFENG

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

HUOXUESHUFENG is a traditional Chinese medicine formulation used primarily for the treatment of migraine. It is referenced in clinical trial registries as "HUOXUESHUFENG grain" and appears to be a multi-ingredient herbal preparation rather than a single chemical entity. The specific composition and mechanism of action are not detailed in the available sources, but such formulations typically aim to promote blood circulation ("huoxue") and relieve wind ("shufeng"), concepts rooted in traditional Chinese medicine theory. There is at least one registered clinical study evaluating its effectiveness and safety for migraine management[2].

Brand names: HUOXUESHUFENG
Other names: Huoxue ShufengHuoxueshufeng grain活血舒风

Targets

NF-κBTLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on HUOXUESHUFENG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HUOXUESHUFENG.

Explore the full profile